- Who We Are
- Clinician Employment
- Publications
- Witness to Witness (W2W)
- El Premio Kugel & Zuroweste a la Justicia en la Salud
- Your Voice Matters: Photovoice Project
Inscription In Drug Use Among Farm Workers
Excerpts from "Inscription In Drug Use Among Farm Workers," Original (unpublished) research by Dr. Keith Bletzer.
Instructions for applying for IRB-3R
Instructions for applying for IRB-3R
Instructions for applying for IRB-3R
Instructions for applying for IRB-3R
Interim VIS for Human Papillomavirus vaccine
On September 5, CDC released an interim VIS for human
papillomavirus (HPV) vaccine. The final VIS will be developed
after ACIP recommendations are published in MMWR and the vaccine
is covered by the Vaccine Injury Compensation Program.
Interim VIS for Human Papillomavirus vaccine
On September 5, CDC released an interim VIS for human
papillomavirus (HPV) vaccine. The final VIS will be developed
after ACIP recommendations are published in MMWR and the vaccine
is covered by the Vaccine Injury Compensation Program.
Interim VIS for Human Papillomavirus vaccine
On September 5, CDC released an interim VIS for human
papillomavirus (HPV) vaccine. The final VIS will be developed
after ACIP recommendations are published in MMWR and the vaccine
is covered by the Vaccine Injury Compensation Program.
Interim VIS for Human Papillomavirus vaccine
On September 5, CDC released an interim VIS for human
papillomavirus (HPV) vaccine. The final VIS will be developed
after ACIP recommendations are published in MMWR and the vaccine
is covered by the Vaccine Injury Compensation Program.
Interim VIS for Shingles
On September 11, CDC released an interim VIS for shingles
(herpes zoster) vaccine. ACIP has not yet voted on
recommendations for zoster vaccine. The interim VIS is based
primarily on information from the manufacturer's package insert.
The final VIS will be produced after the ACIP recommendations
have been published in MMWR. The final VIS could differ from the
interim version.
